Responsive image

Common name

isobutane

IUPAC name

isobutane

SMILES

C(C)(C)C

Common name

isobutane

IUPAC name

isobutane

SMILES

C(C)(C)C

INCHI

InChI=1S/C4H10/c1-4(2)3/h4H,1-3H3

FORMULA

C4H10

Responsive image

Common name

isobutane

IUPAC name

isobutane





Molecular weight

58.122

clogP

0.723

clogS

-0.909

Frequency

0.0611





HBond Acceptor

0

HBond Donor

0

Total Polar
Surface Area

0

Number of Rings

0

Rotatable Bond

0

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00717 Terbinafine Responsive image Antifungal Agents; Dermatologicals; Antifungals for Topical Use; Antifungals for Dermatological Use; Antifungals for Systemic Use; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; For the treatment of dermatophyte infections of the toenail or fingernail caused by susceptible fungi. Also for the treatment of tinea capitis (scalp ringworm) and tinea corporis (body ringworm) or tinea cruris (jock itch).
FDBD00731 Terbutaline Responsive image Sympathomimetics; Adrenergic beta-2 Receptor Agonists; Bronchodilator Agents; Tocolytic Agents; Respiratory System; Drugs for Obstructive Airway Diseases; Selective Beta-2-Adrenoreceptor Agonists; Adrenergics, Inhalants; Adrenergics for Systemic Use; Beta2 Agonists; For the prevention and reversal of bronchospasm in patients 12 years of age and older with reversible, obstructive airway disease, as well as symptomatic management of reversible bronchospasm associated with bronchitis and emphysema. Also used acute IV and sub-Q therapy in selected women to inhibit uterine contractions in preterm labor (tocolysis) and prolong gestation when beneficial.
FDBD00769 Repaglinide Responsive image Hypoglycemic Agents; Antidiabetic Agents; Meglitinides; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C8 Inducers; CYP3A4 Inhibitors; As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
FDBD00778 Buprenorphine Responsive image Analgesics; Analgesics, Opioid; Narcotics; Narcotic Antagonists; Nervous System; Drugs Used in Addictive Disorders; Opioids; Drugs Used in Opioid Dependence; Oripavine Derivatives; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.
FDBD00790 Oxymetazoline Responsive image Sympathomimetics; Adrenergic alpha-Agonists; Nasal Decongestants; Respiratory System; Ophthalmologicals; Sensory Organs; Nasal Preparations; Sympathomimetics, Plain; Sympathomimetics Used as Decongestants; Decongestants and Antiallergics; Alpha2 Agonists; For treatment of nasal congestion and redness associated with minor irritations of the eye.
FDBD00855 Salbutamol Responsive image Adrenergic beta-2 Receptor Agonists; Bronchodilator Agents; Tocolytic Agents; Respiratory System; Drugs for Obstructive Airway Diseases; Selective Beta-2-Adrenoreceptor Agonists; Adrenergics, Inhalants; Adrenergics for Systemic Use; CYP3A4 Inhibitors; Beta2 Agonists; For symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, and other chronic bronchopulmonary disorders such as COPD.
FDBD00876 Phylloquinone Responsive image Vitamins; Antifibrinolytic Agents; Vitamin K; Blood and Blood Forming Organs; Antihemorrhagics; For the treatment of haemorrhagic conditions in infants, antidote for coumarin anticoagulants in hypoprothrombinaemia.
FDBD00902 Ibuprofen Responsive image For symptomatic treatment of rheumatoid arthritis, juvenile rheumatoid arthritis and osteoarthritis. May be used to treat mild to moderate pain and for the management of dysmenorrhea. May be used to reduce fever. Has been used with some success for treating ankylosing spondylitis, gout and psoriatic arthritis. May reduce pain, fever and inflammation of pericarditis. May be used IV with opiates to relieve moderate to severe pain. Ibuprofen lysine may be used IV to treat patent ductus arteriosus (PDA) in premature neonates.
FDBD00923 Atazanavir Responsive image Anti-HIV Agents; Protease Inhibitors; HIV Protease Inhibitors; Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.
FDBD00941 Butenafine Responsive image Antifungal Agents; Dermatologicals; Antifungals for Topical Use; Antifungals for Dermatological Use; For the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to .
178 , 18
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
4m3f_ligand_1_3.mol2 4m3f 1 -6.56 CC(C)C 4
3cvk_ligand_1_3.mol2 3cvk 1 -6.55 CC(C)(C)C 5
1usk_ligand_1_1.mol2 1usk 1 -6.54 CC(C)C 4
4hmk_ligand_1_1.mol2 4hmk 1 -6.53 CC(C)C 4
3f3e_ligand_1_1.mol2 3f3e 1 -6.51 C(C)(C)C 4
3gjd_ligand_1_1.mol2 3gjd 1 -6.50 CC(C)C 4
4hod_ligand_1_1.mol2 4hod 1 -6.48 CC(C)C 4
1yt7_ligand_1_7.mol2 1yt7 1 -6.46 CC(C)(C)C 5
6909 , 691